Singleron Biotechnologies Funding: $100M Raised, Series A
Singleron Biotechnologies is based in Cologne, Germany. It has raised $100M in total funding. Latest round: Series A.
Singleron Biotechnologies funding overview
Singleron Biotechnologies is based in Cologne, Germany. Singleron Biotechnologies has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2020. The round record for Singleron Biotechnologies runs through 2020; nothing later has been disclosed. Investors on record include Oriza Seed, Sherpa Healthcare Partners, Lilly Asia Ventures. 3 distinct backers are named across the disclosed rounds.
Singleron Biotechnologies at a glance
Total raised
$100M
Latest round
Series A
Latest round date
September 2020
Headquarters
Cologne, Germany
Notable investors
Oriza Seed, Sherpa Healthcare Partners, Lilly Asia Ventures
Frequently asked about Singleron Biotechnologies funding
How much has Singleron Biotechnologies raised?
Singleron Biotechnologies has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Singleron Biotechnologies?
Oriza Seed, Sherpa Healthcare Partners, Lilly Asia Ventures are named among the investors backing Singleron Biotechnologies.
What was the latest Singleron Biotechnologies funding round?
The most recent disclosed round is a Series A, announced in September 2020.
Where is Singleron Biotechnologies based?
Singleron Biotechnologies is based in Cologne, Germany.
When did Singleron Biotechnologies last raise?
The last disclosed Singleron Biotechnologies round closed in September 2020 at Series A.
Totals shown for Singleron Biotechnologies aggregate every disclosed round on file. To see how that compares, browse the companies in Cologne and the investors behind them below.
Companies related to Singleron Biotechnologies (12)
